ID CPNS1_RAT Reviewed; 270 AA. AC Q64537; P97572; Q4V795; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 06-DEC-2005, sequence version 3. DT 24-JAN-2024, entry version 176. DE RecName: Full=Calpain small subunit 1; DE Short=CSS1; DE AltName: Full=Calcium-activated neutral proteinase small subunit; DE Short=CANP small subunit; DE AltName: Full=Calcium-dependent protease small subunit; DE Short=CDPS; DE AltName: Full=Calcium-dependent protease small subunit 1; DE AltName: Full=Calpain regulatory subunit; GN Name=Capns1; Synonyms=Capn4, Css1; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 4-270. RX PubMed=8950173; DOI=10.1016/s0167-4781(96)00135-2; RA Sorimachi H., Amano S., Ishiura S., Suzuki K.; RT "Primary sequences of rat mu-calpain large and small subunits are, RT respectively, moderately and highly similar to those of human."; RL Biochim. Biophys. Acta 1309:37-41(1996). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] OF 87-270, PARTIAL PROTEIN SEQUENCE, DOMAIN, RP SUBUNIT, AND X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 84-266. RX PubMed=7982961; DOI=10.1016/s0021-9258(18)43835-5; RA Graham-Siegenthaler K., Gauthier S., Davies P.L., Elce J.S.; RT "Active recombinant rat calpain II. Bacterially produced large and small RT subunits associate both in vivo and in vitro."; RL J. Biol. Chem. 269:30457-30460(1994). RN [4] RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 98-270 IN COMPLEX WITH CALCIUM, RP SUBUNIT, AND DOMAIN. RX PubMed=9228945; DOI=10.1038/nsb0797-532; RA Blanchard H., Grochulski P., Li Y., Arthur J.S.C., Davies P.L., Elce J.S., RA Cygler M.; RT "Structure of a calpain Ca(2+)-binding domain reveals a novel EF-hand and RT Ca(2+)-induced conformational changes."; RL Nat. Struct. Biol. 4:532-538(1997). RN [5] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 91-249, DOMAIN, AND SUBUNIT. RX PubMed=14579356; DOI=10.1002/prot.10453; RA Leinala E.K., Arthur J.S., Grochulski P., Davies P.L., Elce J.S., Jia Z.; RT "A second binding site revealed by C-terminal truncation of calpain small RT subunit, a penta-EF-hand protein."; RL Proteins 53:649-655(2003). RN [6] RP X-RAY CRYSTALLOGRAPHY (2.86 ANGSTROMS) OF 88-270, AND SUBUNIT. RX PubMed=15476820; DOI=10.1016/j.jmb.2004.08.073; RA Hosfield C.M., Elce J.S., Jia Z.; RT "Activation of calpain by Ca2+: roles of the large subunit N-terminal and RT domain III-IV linker peptides."; RL J. Mol. Biol. 343:1049-1053(2004). RN [7] RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 88-270 IN COMPLEX WITH CAPN2 AND RP CALPASTATIN, CALCIUM-BINDING SITES, AND SUBUNIT. RX PubMed=19020623; DOI=10.1038/nature07451; RA Hanna R.A., Campbell R.L., Davies P.L.; RT "Calcium-bound structure of calpain and its mechanism of inhibition by RT calpastatin."; RL Nature 456:409-412(2008). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 88-270 IN COMPLEX WITH CAPN2 AND RP CALPASTATIN, CALCIUM-BINDING SITES, AND SUBUNIT. RX PubMed=19020622; DOI=10.1038/nature07353; RA Moldoveanu T., Gehring K., Green D.R.; RT "Concerted multi-pronged attack by calpastatin to occlude the catalytic RT cleft of heterodimeric calpains."; RL Nature 456:404-408(2008). CC -!- FUNCTION: Regulatory subunit of the calcium-regulated non-lysosomal CC thiol-protease which catalyzes limited proteolysis of substrates CC involved in cytoskeletal remodeling and signal transduction. Essential CC for embryonic development (By similarity). CC {ECO:0000250|UniProtKB:O88456}. CC -!- SUBUNIT: Homodimer or heterodimer of a large (catalytic) and a small CC (regulatory) subunit. In presence of calcium, the heterodimer CC dissociates (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q64537; Q07009: Capn2; NbExp=8; IntAct=EBI-918712, EBI-1040438; CC -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane. Note=Translocates to CC the plasma membrane upon calcium binding (By similarity). Allows the CC formation of the homodimer and also appears to mediate the contact CC between the large catalytic subunit and small regulatory subunit for CC the formation of the heterodimer. {ECO:0000250}. CC -!- DOMAIN: The contact of the 5th EF-hand domain from each monomer allows CC the formation of the homodimer and also appears to mediate the contact CC between the large catalytic subunit and small regulatory subunit for CC the formation of the heterodimer. CC -!- DOMAIN: EF-hand domains are paired. EF-hand 1 is paired with EF-hand 2 CC and EF-hand 3 is paired with EF-hand 4. The fifth EF-hand domain, left CC unpaired, does not bind the calcium but is responsible of the CC dimerization by EF-embrace. The first four EF-hand domains bind CC calcium, however it is not sure if the binding of EF-hand 4 to calcium CC is physiologically relevant. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; BC098068; AAH98068.1; -; mRNA. DR EMBL; U53859; AAC53002.1; -; mRNA. DR EMBL; U10861; AAA64828.1; -; mRNA. DR PIR; A55143; A55143. DR RefSeq; NP_058814.1; NM_017118.1. DR RefSeq; XP_017445520.1; XM_017590031.1. DR PDB; 1AJ5; X-ray; 2.30 A; A/B=98-270. DR PDB; 1DF0; X-ray; 2.60 A; B=88-270. DR PDB; 1DVI; X-ray; 2.30 A; A/B=88-270. DR PDB; 1NP8; X-ray; 2.00 A; A/B=91-249. DR PDB; 1QXP; X-ray; 2.80 A; A/B=88-270. DR PDB; 1U5I; X-ray; 2.86 A; B=88-270. DR PDB; 3BOW; X-ray; 2.40 A; B=88-270. DR PDB; 3DF0; X-ray; 2.95 A; B=87-270. DR PDBsum; 1AJ5; -. DR PDBsum; 1DF0; -. DR PDBsum; 1DVI; -. DR PDBsum; 1NP8; -. DR PDBsum; 1QXP; -. DR PDBsum; 1U5I; -. DR PDBsum; 3BOW; -. DR PDBsum; 3DF0; -. DR AlphaFoldDB; Q64537; -. DR SMR; Q64537; -. DR DIP; DIP-6140N; -. DR IntAct; Q64537; 4. DR MINT; Q64537; -. DR STRING; 10116.ENSRNOP00000064489; -. DR iPTMnet; Q64537; -. DR PhosphoSitePlus; Q64537; -. DR jPOST; Q64537; -. DR PaxDb; 10116-ENSRNOP00000064489; -. DR Ensembl; ENSRNOT00055057849; ENSRNOP00055047732; ENSRNOG00055033452. DR Ensembl; ENSRNOT00060050154; ENSRNOP00060041793; ENSRNOG00060028834. DR Ensembl; ENSRNOT00065058591; ENSRNOP00065048239; ENSRNOG00065034103. DR GeneID; 29156; -. DR KEGG; rno:29156; -. DR UCSC; RGD:2270; rat. DR AGR; RGD:2270; -. DR CTD; 826; -. DR RGD; 2270; Capns1. DR eggNOG; KOG0037; Eukaryota. DR InParanoid; Q64537; -. DR OrthoDB; 4075143at2759; -. DR PhylomeDB; Q64537; -. DR BRENDA; 3.4.22.B24; 5301. DR Reactome; R-RNO-1474228; Degradation of the extracellular matrix. DR EvolutionaryTrace; Q64537; -. DR PRO; PR:Q64537; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0110158; C:calpain complex; ISO:RGD. DR GO; GO:0005829; C:cytosol; ISO:RGD. DR GO; GO:0016020; C:membrane; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell. DR GO; GO:0005509; F:calcium ion binding; TAS:RGD. DR GO; GO:0004198; F:calcium-dependent cysteine-type endopeptidase activity; ISO:RGD. DR GO; GO:0044877; F:protein-containing complex binding; IPI:RGD. DR GO; GO:0030163; P:protein catabolic process; IMP:RGD. DR CDD; cd16188; EFh_PEF_CPNS1_2; 1. DR Gene3D; 1.10.238.10; EF-hand; 1. DR InterPro; IPR011992; EF-hand-dom_pair. DR InterPro; IPR018247; EF_Hand_1_Ca_BS. DR InterPro; IPR002048; EF_hand_dom. DR PANTHER; PTHR46735:SF1; CALPAIN SMALL SUBUNIT 1; 1. DR PANTHER; PTHR46735; CALPAIN, SMALL SUBUNIT 1 A-RELATED; 1. DR Pfam; PF13833; EF-hand_8; 1. DR SUPFAM; SSF47473; EF-hand; 1. DR PROSITE; PS00018; EF_HAND_1; 2. DR PROSITE; PS50222; EF_HAND_2; 3. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Calcium; Cell membrane; Cytoplasm; KW Direct protein sequencing; Membrane; Metal-binding; Phosphoprotein; KW Reference proteome; Repeat. FT CHAIN 1..270 FT /note="Calpain small subunit 1" FT /id="PRO_0000073717" FT DOMAIN 98..132 FT /note="EF-hand 1; atypical" FT /evidence="ECO:0000305" FT DOMAIN 141..174 FT /note="EF-hand 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 171..206 FT /note="EF-hand 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT DOMAIN 207..235 FT /note="EF-hand 4" FT /evidence="ECO:0000305" FT DOMAIN 236..270 FT /note="EF-hand 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448" FT BINDING 111 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT BINDING 114 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT BINDING 116 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT BINDING 121 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT BINDING 139 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT BINDING 154 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 156 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 158 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 160 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 165 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 184 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 186 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 188 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 190 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 195 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00448, FT ECO:0000269|PubMed:19020622, ECO:0000269|PubMed:19020623, FT ECO:0000269|PubMed:9228945, ECO:0007744|PDB:1DVI, FT ECO:0007744|PDB:3BOW, ECO:0007744|PDB:3DF0" FT BINDING 227 FT /ligand="Ca(2+)" FT /ligand_id="ChEBI:CHEBI:29108" FT /ligand_label="4" FT /evidence="ECO:0000269|PubMed:19020622, FT ECO:0000269|PubMed:19020623, ECO:0000269|PubMed:9228945, FT ECO:0007744|PDB:1DVI, ECO:0007744|PDB:3BOW, FT ECO:0007744|PDB:3DF0" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0000250|UniProtKB:P04632" FT MOD_RES 6 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P04632" FT MOD_RES 181 FT /note="N6-acetyllysine" FT /evidence="ECO:0000250|UniProtKB:P04632" FT CONFLICT 87 FT /note="S -> M (in Ref. 3; AAA64828)" FT /evidence="ECO:0000305" FT HELIX 98..111 FT /evidence="ECO:0007829|PDB:1NP8" FT HELIX 112..114 FT /evidence="ECO:0007829|PDB:1NP8" FT HELIX 119..132 FT /evidence="ECO:0007829|PDB:1NP8" FT TURN 134..136 FT /evidence="ECO:0007829|PDB:1AJ5" FT HELIX 143..153 FT /evidence="ECO:0007829|PDB:1NP8" FT STRAND 158..161 FT /evidence="ECO:0007829|PDB:1NP8" FT HELIX 163..183 FT /evidence="ECO:0007829|PDB:1NP8" FT STRAND 188..191 FT /evidence="ECO:0007829|PDB:1NP8" FT TURN 193..195 FT /evidence="ECO:0007829|PDB:1NP8" FT HELIX 196..202 FT /evidence="ECO:0007829|PDB:1NP8" FT HELIX 209..219 FT /evidence="ECO:0007829|PDB:1NP8" FT STRAND 224..226 FT /evidence="ECO:0007829|PDB:1DVI" FT HELIX 228..243 FT /evidence="ECO:0007829|PDB:1NP8" FT TURN 248..251 FT /evidence="ECO:0007829|PDB:1DF0" FT STRAND 253..258 FT /evidence="ECO:0007829|PDB:1DVI" FT HELIX 260..268 FT /evidence="ECO:0007829|PDB:1AJ5" SQ SEQUENCE 270 AA; 28570 MW; 63609614CD4D3EB7 CRC64; MFLVNSFLKG GGGGGGGGGL GGGLGNVLGG LISGAAGGGG GGGGGGGMGL GGGGGGGGTA MRILGGVISA ISEAAAQYNP EPPPPRSHYS NIEANESEEE RQFRKLFVQL AGDDMEVSAT ELMNILNKVV TRHPDLKTDG FGIDTCRSMV AVMDSDTTGK LGFEEFKYLW NNIKKWQGIY KRFDTDRSGT IGSNELPGAF EAAGFHLNQH IYSMIIRRYS DETGNMDFDN FISCLVRLDA MFRAFRSLDK NGTGQIQVNI QEWLQLTMYS //